DrugPatentWatch Database Preview
Drugs in Development Information for Sitaxentan
Development status for investigational drug Sitaxentan: Sponsors, patents, clinical trial progress
Sitaxentan is an investigational drug.
There have been 10 clinical trials for Sitaxentan.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Familial Primary Pulmonary Hypertension, Hypertension, and Hypertension, Pulmonary. The leading clinical trial sponsors are Pfizer, Encysive Pharmaceuticals, and Institut National de la Santé Et de la Recherche Médicale, France.
There are twenty-one US patents protecting this investigational drug and seven hundred and twenty-one international patents.
Summary for Sitaxentan
| US Patents | 21 |
| International Patents | 721 |
| US Patent Applications | 130 |
| WIPO Patent Applications | 107 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2010-11-01) |
| Vendors | 32 |
Recent Clinical Trials for Sitaxentan
| Title | Sponsor | Phase |
|---|---|---|
| Drug Interaction Between Ritonavir And Sitaxsentan | Pfizer | Phase 1 |
| Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension Patients | Pfizer | Phase 3 |
| A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses | Pfizer | Phase 1 |
Clinical Trial Summary for Sitaxentan
Top disease conditions for Sitaxentan
Top clinical trial sponsors for Sitaxentan
US Patents for Sitaxentan
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Sitaxentan | Start Trial | Method for preventing or treating erectile dysfunction by administering an endothelin antagonist | Bristol-Myers Squibb Company (Princeton, NJ) | Start Trial |
| Sitaxentan | Start Trial | Method for preventing or treating pain by administering an endothelin antagonist | Bristol-Myers Squibb Co. (Princeton, NJ) | Start Trial |
| Sitaxentan | Start Trial | Sulfonamides and derivatives thereof that modulate the activity of endothelin | Encysive Pharmaceuticals Inc. (Bellaire, TX) | Start Trial |
| Sitaxentan | Start Trial | Sulfamidothienopyrimidines | Merck Patent GmbH (Darmstadt, DE) | Start Trial |
| Sitaxentan | Start Trial | Amide derivatives as inhibitors of the enzymatic activity of renin | Novartis AG (Basel, CH) | Start Trial |
| Sitaxentan | Start Trial | Pyrimidine derivatives | Merck Patent GmbH (Darmstadt, DE) | Start Trial |
| Sitaxentan | Start Trial | Respiratory drug condensation aerosols and methods of making and using them | Alexza Pharmaceuticals, Inc. (Mountain View, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Sitaxentan
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Sitaxentan | Argentina | 247246 | 2011-10-22 | Start Trial |
| Sitaxentan | Austria | 174592 | 2011-10-22 | Start Trial |
| Sitaxentan | Austria | 198146 | 2011-10-22 | Start Trial |
| Sitaxentan | Austria | 225635 | 2011-10-22 | Start Trial |
| Sitaxentan | Austria | 243203 | 2011-10-22 | Start Trial |
| Sitaxentan | Austria | 270669 | 2011-10-22 | Start Trial |
| Sitaxentan | Australia | 2711192 | 2011-10-22 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
